Laboratory Capacity Building in Asia for Infectious Disease Research: Experiences from the South East Asia Infectious Disease Clinical Research Network (SEAICRN)
article has not abstract
Vyšlo v časopise:
Laboratory Capacity Building in Asia for Infectious Disease Research: Experiences from the South East Asia Infectious Disease Clinical Research Network (SEAICRN). PLoS Med 7(4): e32767. doi:10.1371/journal.pmed.1000231
Kategorie:
Health in Action
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000231
Souhrn
article has not abstract
Zdroje
1. HiggsES
HaydenFG
ChotpitayasunondhT
WhitworthJ
FarrarJ
2008 The Southeast Asian Influenza Clinical Research Network: development and challenges for a new multilateral research endeavor. Antiviral Res 78 64 68
2. 2005 World Health Assembly. Strengthening pandemic-influenza preparedness and response:WHA58.5. May 2005. Available: http://wwwwhoint/gb/ebwha/pdf_files/WHA58/WHA58_5-enpdf Accessed 21 April 2009
3. PLoS Medicine Editors 2007 How is WHO responding to global public health threats? PLoS Med 4 e197 doi:10.1371/journal.pmed.0040197
4. EzzelleJ
Rodriguez-ChavezIR
DardenJM
StirewaltM
KunwarN
2008 Guidelines on good clinical laboratory practice: bridging operations between research and clinical research laboratories. J Pharm Biomed Anal 46 18 29
5. StevensW
2003 Good clinical laboratory practice (GCLP): the need for a hybrid of good laboratory practice and good clinical practice guidelines/standards for medical testing laboratories conducting clinical trials in developing countries. Qual Assur 10 83 89
6. WertheimHF
NguyenHN
TaylorW
LienTT
NgoHT
2009 Streptococcus suis, an important cause of adult bacterial meningitis in northern Vietnam. PLoS One 4 e5973 doi:10.1371/journal.pone.0005973
7. SheuTG
DeydeVM
Okomo-AdhiamboM
GartenRJ
XuX
2008 Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob Agents Chemother 52 3284 3292
8. BesselaarTG
NaidooD
BuysA
GregoryV
McAnerneyJ
2008 Widespread oseltamivir resistance in influenza A viruses (H1N1), South Africa. Emerg Infect Dis 14 1809 1810
9. LeQM
WertheimHF
TranND
van DoornHR
NguyenTH
HorbyP
2010 A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza. N Engl J Med 362 86 87
10. BurnettD
BlairC
2001 Standards for the medical laboratory–harmonization and subsidiarity. Clin Chim Acta 309 137 145
11. KuepferI
BurriC
2009 Reflections on clinical research in sub-Saharan Africa. Int J Parasitol 39 947 954
12. KrukME
2008 Emergency preparedness and public health systems lessons for developing countries. Am J Prev Med 34 529 534
13. WattanagoonY
StepniewskaK
LindegardhN
PukrittayakameeS
SilachamroonU
2009 Pharmacokinetics of high-dose oseltamivir in healthy volunteers. Antimicrob Agents Chemother 53 945 952
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2010 Číslo 4
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Co dělat při intoleranci statinů?
- Pleiotropní účinky statinů na kardiovaskulární systém
- DESATORO PRE PRAX: Aktuálne odporúčanie ESPEN pre nutričný manažment u pacientov s COVID-19
Najčítanejšie v tomto čísle
- Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
- Economic Appraisal of Ontario's Universal Influenza Immunization Program: A Cost-Utility Analysis
- China's Engagement with Global Health Diplomacy: Was SARS a Watershed?
- Laboratory Capacity Building in Asia for Infectious Disease Research: Experiences from the South East Asia Infectious Disease Clinical Research Network (SEAICRN)